Background: Community-acquired pneumonia (CAP) is the leading infectious cause of mortality among children worldwide. Although Lung ultrasound (LUS) has demonstrated high diagnostic accuracy for pediatric CAP, its role in guiding management and treatment decisions is still unclear. We assessed whether adding LUS to standard care (SoC) reduces antibiotic prescribing and evaluated its effects on clinical decisions, emergency department length of stay, hospital admission, and unscheduled visits. Materials and methods: We analyzed interim data from a prospective, multicenter, randomized clinical trial (LUSCAP). Children aged 3 to 10 years presenting to the pediatric Emergency Department (ED) with suspected pneumonia were enrolled. Participants were randomized to control arm (SoC alone) or intervention arm (SoC+ LUS). Clinical outcomes were assessed at one-week follow-up. Patient data were collected on REDCap platform. Analyses included the Padua center cohort and the multicenter interim cohort. Results: The analysis included 35 patients from Padova and 251 from the multicenter cohort. In Padua, antibiotic prescriptions were lower in the LUS arm (27.8% vs 43.7%); the adjusted multicenter estimate also favored LUS (adjusted OR 0.58, 95%CI 0.30–1.15). Neither comparison reached statistical significance. After LUS, pneumonia-likelihood assessments shifted away from intermediate categories toward “very likely” or “very unlikely.” Chest radiography use was numerically lower with LUS in Padua (27.8% vs 43.7%) and significantly lower in the multicenter cohort (14.5% vs 34.1%, p < 0.001). No significant between-group differences were observed in ED length of stay, hospitalization, or unscheduled visits. Conclusions: In this study, LUS demonstrated two complementary effects on clinical decision-making: strengthening pneumonia suspicion when major consolidations were found and lowering it in cases of minor or normal findings. The interim results do not establish a reduction in antibiotic prescribing or differences in follow-up outcomes; the analysis of the complete sample will be necessary to reach definitive conclusions.
Background: Community-acquired pneumonia (CAP) is the leading infectious cause of mortality among children worldwide. Although Lung ultrasound (LUS) has demonstrated high diagnostic accuracy for pediatric CAP, its role in guiding management and treatment decisions is still unclear. We assessed whether adding LUS to standard care (SoC) reduces antibiotic prescribing and evaluated its effects on clinical decisions, emergency department length of stay, hospital admission, and unscheduled visits. Materials and methods: We analyzed interim data from a prospective, multicenter, randomized clinical trial (LUSCAP). Children aged 3 to 10 years presenting to the pediatric Emergency Department (ED) with suspected pneumonia were enrolled. Participants were randomized to control arm (SoC alone) or intervention arm (SoC+ LUS). Clinical outcomes were assessed at one-week follow-up. Patient data were collected on REDCap platform. Analyses included the Padua center cohort and the multicenter interim cohort. Results: The analysis included 35 patients from Padova and 251 from the multicenter cohort. In Padua, antibiotic prescriptions were lower in the LUS arm (27.8% vs 43.7%); the adjusted multicenter estimate also favored LUS (adjusted OR 0.58, 95%CI 0.30–1.15). Neither comparison reached statistical significance. After LUS, pneumonia-likelihood assessments shifted away from intermediate categories toward “very likely” or “very unlikely.” Chest radiography use was numerically lower with LUS in Padua (27.8% vs 43.7%) and significantly lower in the multicenter cohort (14.5% vs 34.1%, p < 0.001). No significant between-group differences were observed in ED length of stay, hospitalization, or unscheduled visits. Conclusions: In this study, LUS demonstrated two complementary effects on clinical decision-making: strengthening pneumonia suspicion when major consolidations were found and lowering it in cases of minor or normal findings. The interim results do not establish a reduction in antibiotic prescribing or differences in follow-up outcomes; the analysis of the complete sample will be necessary to reach definitive conclusions.
Lung Ultrasound in the Diagnostic Evaluation of Children Presenting with Respiratory Symptoms to the Paediatric Emergency Department: A Pilot Observational Study
TRAVERSO, FRANCESCA
2025/2026
Abstract
Background: Community-acquired pneumonia (CAP) is the leading infectious cause of mortality among children worldwide. Although Lung ultrasound (LUS) has demonstrated high diagnostic accuracy for pediatric CAP, its role in guiding management and treatment decisions is still unclear. We assessed whether adding LUS to standard care (SoC) reduces antibiotic prescribing and evaluated its effects on clinical decisions, emergency department length of stay, hospital admission, and unscheduled visits. Materials and methods: We analyzed interim data from a prospective, multicenter, randomized clinical trial (LUSCAP). Children aged 3 to 10 years presenting to the pediatric Emergency Department (ED) with suspected pneumonia were enrolled. Participants were randomized to control arm (SoC alone) or intervention arm (SoC+ LUS). Clinical outcomes were assessed at one-week follow-up. Patient data were collected on REDCap platform. Analyses included the Padua center cohort and the multicenter interim cohort. Results: The analysis included 35 patients from Padova and 251 from the multicenter cohort. In Padua, antibiotic prescriptions were lower in the LUS arm (27.8% vs 43.7%); the adjusted multicenter estimate also favored LUS (adjusted OR 0.58, 95%CI 0.30–1.15). Neither comparison reached statistical significance. After LUS, pneumonia-likelihood assessments shifted away from intermediate categories toward “very likely” or “very unlikely.” Chest radiography use was numerically lower with LUS in Padua (27.8% vs 43.7%) and significantly lower in the multicenter cohort (14.5% vs 34.1%, p < 0.001). No significant between-group differences were observed in ED length of stay, hospitalization, or unscheduled visits. Conclusions: In this study, LUS demonstrated two complementary effects on clinical decision-making: strengthening pneumonia suspicion when major consolidations were found and lowering it in cases of minor or normal findings. The interim results do not establish a reduction in antibiotic prescribing or differences in follow-up outcomes; the analysis of the complete sample will be necessary to reach definitive conclusions.| File | Dimensione | Formato | |
|---|---|---|---|
|
Traverso_Francesca.pdf
Accesso riservato
Dimensione
2.03 MB
Formato
Adobe PDF
|
2.03 MB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/119127